۱. Ugi Four-Component Reaction Directed Towards The Synthesis of CyclohexylArylacetamide Derivatives of N-(۵-bromo-۲-(۴-phenylpiperazine-۱-yl) phenyl) Arylcarboxamide Scaffold as Novel Alzheimer’s β-secretase inhibitors.Pharmaceutical sciences, ۱۸th Iranian Pharmacy Student Seminar, ۲۰۱۴.

۲. Design, synthesis, biological evaluation and comparative Cox۱ and Cox۲molecular docking study of novel ۱,۲,۴-triazine derivatives. Pharmaceutical sciences, ۱۸th Iranian Pharmacy Student Seminar, ۲۰۱۴

۳. O. Firuzi, N. Edraki, R. Miri, A. Shafiee, A. Foroumadi, A. Madadkar Sobhani. Novel Bromophenyl Piperazine Derivatives as BACE-۱ Inhibitors for Reduction of Amyloid-beta. ۱۱th international conference on Alzheimer's and Parkinson's disease. Felorance, Italy, ۲۰۱۳.

۴. M. Parish , B. Hemmateenejad, R. Miri, N. Edraki, M. Elyasi, M. Khoshneviszadeh, J. Dimmock. Qsar study of N-acyl-۳,۵-bis(arylidene)-۴-piperidones as cytotoxic Agents ۱۳th Iranian Pharmaceutical Sciences Congress, ۲۰۱۲.

۵. N. Razzaghi Asl, R. Miri, A. Ebadi, N. Edraki, S. Shahabipour.Theoretical binding efficiencies in bioactive molecular design: a case study on BACE-۱ inhibitors. ۱۳th Iranian Pharmaceutical Sciences Congress, ۲۰۱۲

۶. A. Asadipour, N. Edraki, M. Nakhjiri, A. Meymandi, E. Alipour, P. Saniee, F. Siavoshi,A. Foroumadi. ۲-alkylthio-۵-(nitroaryl)-۱,۳,۴-thiadiazole derivatives as antihelicobacterpylori agents: investigation of structure-activity relationship. . ۱۳th Iranian Pharmaceutical Sciences Congress, ۲۰۱۲.

۷. Miri R., Javidnia K., Khoshneviszadeh, M, Edraki N. Synthesis and biological evaluation of some new ۱,۴-dihydropyridines containing different ester substitute and diethyl carbamoyl group as anti-tubercular agents. ۲۰th International symposium on medicinal chemistry, Augost ۳۱-September ۴, Vienna, Austria ۲۰۰۸.

۸. Miri, R., Javidnia K., Mirkhani H., Kazemi F., Hemmateenejad B., Edraki N., Mehdipour A.Synthesis and in vitro dual calcium channel antagonist activity of some ۱,۴-dihydro-۲,۶-dimethyl-۳-nitro and cyano-۴-(۱-methyl-۵-nitro-۱H-imidazol-۲-yl)۵-pyridinecarboxylates. ۲۰th International symposium on medicinal chemistry, Augost ۳۱-September ۴, Vienna, Austria ۲۰۰۸.

۹. Khoshneviszadeh M, Hemmateenejad B, Miri R, Edraki N, QSAR study of phenoxypyrimidine derivatives as potent inhibitors of p۳۸ kinase using different chemometric tools, ۱۱th Iranian pharmaceuticl sciences congress, kerman, Iran ۲۰۰۸.
۱۰. Hemmateenejad, B., Miri, R., Edraki, N., Khoshneviszadeh, M., Shafiee, A., QSAR study of ۴-aryl-۴-H-chromenes as a new series of apoptosis inducers using different chemometric tools. ۱۱th Iranian pharmaceutical sciences congress, kerman, Iran ۲۰۰۸.

۱۱. Edraki N, Miri R, Alborzi A, Javidnia K, Khoshneviszadeh M, Pourabbas B, Mardaneh JDesign, Synthesis and biological evaluation of some new ۱,۴-dihydropyridines containing different ester substitute and diethyl carbamoyl group as anti-tubercular agents. ۱۱th Iranian pharmaceutical sciences congress, kerman, Iran ۲۰۰۸.

۱۲. Hemmateenejad, B., Miri, R., Edraki N., Khoshneviszadeh, M., Shafiee, A., (۲۰۰۷) Molecular Modeling and QSAR Analysis of Some ۴,۵-Dichloroimidazolyl-۱,۴-DHP Based Calcium Channel Blockers. The ۸th seminar of Iranian medical sciences. Shiraz. Iran.

۱۳. Hemmatinejad, B., Miri, R., Khoshneviszadeh, M., Edraki N. (۲۰۰۷) Study Of ۱-(Piperidine-۴-yl)-۴-(۴-fluorophenyl)-۵-(۲-phenoxypyrimidin-۴-yl) Imidazoles Deivatives As Potent Inhibitors of p۳۸ Kinase Using Chemometric Tools. The ۸th seminar of Iranian medical sciences. Shiraz. Iran.

۱۴. Hemmatinejad, B., Miri, R., Khoshneviszadeh, M., Edraki N. (۲۰۰۷) Exploring QSAR Of Substitude ۲-Sulfonyl –Phenyl –Indol Deivatives As Potent And Selective COX-۲ Inhibitors Using Chemometric Tools. The ۸th seminar of Iranian medical sciences. Shiraz. Iran.

۱۵. Hemmatinejad, B., Miri, R., Khoshneviszadeh, M., Edraki N. (۲۰۰۶) "Molecular structure and QSAR study on ۴-aryl-۴H-chromenes as new series of apoptosis inducers "۱۰th Iranian Seminar of Pharmaceutical Sciences, ۲۱-۲۴ August, Tehran, Iran.

۱۶. Miri, R., Javidnia, K., Edraki, N., Khoshneviszadeh, M. (۲۰۰۶) "Design and synthesis of new asymmetrical ۱,۴-dihydropyridine derivatives containing alkyl ester as antitubercular agents and evaluation of their calcium-antagonist activity"۱۰th Iranian Seminar of Pharmaceutical Sciences, ۲۱-۲۴ August, Tehran, Iran.

۱۷. Miri, R., Javidnia, K., Khoshneviszadeh, M., Edraki, N. (۲۰۰۶) "Design and synthesis of new asymmetrical ۱,۴-dihydropyridine derivatives containing aryl ester as antitubercular agents and evaluation of their calcium-antagonist activity"۱۰th Iranian Seminar of Pharmaceutical Sciences, ۲۱-۲۴ August, Tehran, Iran.

۱۸. Miri, R., Javidnia, K., Edraki, N., Khoshneviszadeh, M. (۲۰۰۶) "Design and synthesis of new asymmetrical ۱,۴-dihydropyridine derivatives containing alkyl ester as antitubercular agents and evaluation of their calcium-antagonist activity"۷th seminar of Iranian students of medical sciences. Tehran, Iran.

۱۹. Hemmatinejad, B., Miri, R., Khoshneviszadeh, M., Edraki, N., (۲۰۰۶) "The QSAR study of substituted-sulfonyl-phenyl-۳-phenyl-indoles: A new series of selective COX-۲ inhibitors". ۷th seminar of Iranian students of medical sciences. Tehran, Iran.

۲۰. Javidnia, K.,Miri, R., Khoshneviszadeh, M., Edraki, N. (۲۰۰۶) "Synthesis and Evalution of Calcium Channel Antagonist Activity of some New Imidazolyl ۱,۴-Dihidropyridine analogus Containing Carbamoyl Substitute" The ۱۵th Word Congress of Pharmacology, ۲-۷ July, Beijing, China.

۲۱. Javidnia, K., Miri, R., Edraki, N., Nasiri, A., (۲۰۰۵) "Chemical Constituents of the volatile oils of Satureja macrantha from Iran" The ۱st Seminar of Medicinal & Natural Products Chemistry, ۱۰-۱۱ May, Shiraz, Iran.

۲۲. Javidnia, K., Miri, R., Khoshneviszadeh, M., Edraki, N., Javidnia, A., Nasiri, A., (۲۰۰۵) "Constituents of the volatile oil of Artemisia sieberi Besser. From Iran" The ۱st Seminar of Medicinal & Natural Products Chemistry, ۱۰-۱۱ May, Shiraz, Iran.

۲۳. Hemmateenejad, B., Miri, R., Edraki, N., Khoshneviszadeh, M., Shafiee, A., (۲۰۰۵) "Molecular Modeling and QSAR Analysis of Some ۴,۵-Dichloroimidazolyl-۱,۴-DHP Based Calcium Channel Blockers" The ۱st Seminar of Medicinal & Natural Products Chemistry, ۱۰-۱۱ May, Shiraz, Iran.

۲۴. Hemmateenejada, B., Miri, R., Edraki, N., Khoshneviszadeh, M., (۲۰۰۵) "The QSAR study of Substituted ۲-Sulfonyl-phenyl-۳-phenyl-indoles: A New Series of Selective COX-۲ Inhibitors" The ۱st Seminar of Medicinal & Natural Products Chemistry, ۱۰-۱۱ May, Shiraz, Iran.
۲۵. Miri, R.,Javidnia, K.,Khoshneviszadeh, M. Edraki, N.,Javidnia, A., Nasiri. A. (۲۰۰۵) "Constituents of the volatile oil of Artemisia sieberi Besser. from Iran" The ۳۶th international Symposium on Essential Oils, ۴-۷ Sept., Budapest, Hungary.

۲۶. Javidnia, K., Edraki, N.,Khoshneviszadeh, M., Miri, R., Kamalinejad, M. (۲۰۰۴) " Composition of the essential oil of Ferula persica willd" The ۱۰th Seminar of Iranian Pharmacy Students, ۶-۸ Oct., Mashhad, Iran.

۲۷. Javidnia, K., Edraki, N.,Khoshneviszadeh, M., Miri, R (۲۰۰۴) Constituents of the volatile oil of Artemisia sieberi Besser. from Iran. The ۱۰th Seminar of Iranian Pharmacy Students, ۶-۸ Oct., Mashhad, Iran.

۲۸. Hemmateenejad, B., Miri, R., Safarpour, M. A., Edraki, N., Khoshneviszadeh, M.(۲۰۰۴) "Conformational analysis of some new derivatives of ۴-nitroimidazolyl-۱,۴-dihydropyridine-based calcium channel blockers". The ۱۰th Seminar of Iranian Pharmacy Students, ۶-۸ Oct., Mashhad, Iran.

۲۹. Javidnia, K.,Miri, R., Edraki, N., Khoshneviszadeh, M.(۲۰۰۴) "Composition of the essential oil of Artemisia aucheri" ۹th Iranian Seminar of Pharmaceutical Sciences, ۲-۵ August, Tabriz, Iran.

۳۰. Hemmateenejad, B., Miri, R., Safarpour, M. A., Edraki, N., Khoshneviszadeh, M.(۲۰۰۴) "Conformational analysis of some new derivatives of ۴-nitroimidazolyl-۱,۴-dihydropyridine-based calcium channel blockers"۹th Iranian Seminar of Pharmaceutical Sciences, ۲-۵ August, Tabriz, Iran.

۳۱. Javidnia, K.,Miri, R., Edraki, N., Khoshneviszadeh, M. (۲۰۰۴) Chemical composition of the essential oil of Ferula persica Willd. ۹th Iranian Seminar of Pharmaceutical Sciences, ۲-۵ August, Tabriz, Iran.

۳۲. Miri, R., Hemmateenejad, B., Safarpour, M. A., Khoshneviszadeh, M., Edraki, N. (۲۰۰۴) "Conformational analysis of some new derivatives of ۴-nitroimidazolyl-۱,۴-dihydropyridine-based calcium channel blockers" The ۱۵th European Symposium on QSAR & Molecular Modeling, ۵-۱۰ Sept., Istanbul, Turkey.

۳۳. Miri, R., Javidnia, K., Kamalinejad, M. Edraki, N. (۲۰۰۴) " Analysis of the volatile constituents of Ferula persica Willd. from Iran" ۳۵th International Symposium on Essential Oils, ۲۹ Sept.- ۲ Oct., Messina, Italy.

۳۴. Javidnia, K.,Miri, R., Edraki, N., Khoshneviszadeh, M. (۲۰۰۳) " Analysis and comparision of the chemical constituents of the essential oil of aerial part and root of Dracocephalum kotsychi" ۹thSeminar of Iranian Pharmacy Students, Tabriz, Iran.

۳۵. Miri, R., Khoshneviszadeh, M., Edraki, N. (۲۰۰۲) "The assessment of Warfarin side effects in shirazian patients"۸th Iranian Seminar of Pharmaceutical Sciences, ۲۷-۲۹ August, Shiraz, Iran.

۳۶. Miri, R., Khoshneviszadeh, M., Edraki, N. (۲۰۰۲) "The viewpoint of students of Shiraz universities about drug therapy"۸th Iranian Seminar of Pharmaceutical Sciences, ۲۷-۲۹ August, Shiraz, Iran.